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W
ith its powerful genetics and rapid generation 
time, the fruit ﬂ  y, Drosophila, provides crucial 
insights into the evolution and conservation of 
fundamental immune mechanisms. The best example of 
molecules discovered in the ﬂ  y that are shared in human 
immunity operate in the Toll signaling pathway, one of ﬁ  rst 
lines of defense against pathogens. Drosophila can also beneﬁ  t 
human health by providing a model for immune systems of 
arthropod vectors of infectious disease. Additionally, from a 
comparative immunological perspective, it is useful to know 
how different organisms have evolved solutions for ﬁ  ghting 
infections, because this information can lead to new ways of 
thinking about disease.
At a simple level, it is clear that many immune responses 
are designed to turn on when needed, presumably because 
their constitutive expression would be deleterious. After 
induction, immune responses must also be turned off, for the 
same reason they are not left on from birth. The resolution 
of inﬂ  ammation in humans occurs through a complex active 
signaling program [1]. This negative regulation is important 
because excessive inﬂ  ammation leads to pathology and 
death. The ﬂ  y served as a good model for the induction of 
an innate immune response, pointing to conserved pathways 
and mechanisms. Recent work shows that the ﬂ  y’s immune 
response is more subtly regulated and produces a wider range 
of responses than was thought possible even just a few years 
ago. Speciﬁ  cally, this new work shows that the ﬂ  y immune 
response is edited and repressed. These newly discovered 
systems provide us with an opportunity to study both immune 
signaling and the pathology that can result from unregulated 
immune responses, and they promise to teach us about 
mechanisms that might be translated back to human health.
Two Major Pattern-Recognition Pathways Control Fly 
Immunity
In the ﬂ  y, two well-described signaling pathways (Toll 
and imd) respond to microbial elicitors and induce the 
transcription of antimicrobial peptide (AMP) genes [2]. 
Experiments that analyzed infections in mutant ﬂ  ies showed 
that Toll signaling is required for ﬁ  ghting some fungi, viruses, 
Gram-positive bacteria, and Gram-negative bacteria and that 
the imd pathway is involved in ﬁ  ghting some Gram-positive 
and Gram-negative bacteria. Many types of microbes and 
microbial components remain to be tested. Additionally, 
some unexpected elicitors have been identiﬁ  ed; for example, 
sex peptides in ejaculate can induce the immune response 
in the female Drosophila genital tract in a Toll- and imd-
dependent manner [3].
Signaling through the Toll and imd pathways leads to 
the activation and translocation of NF-κB–like proteins into 
the nuclei of activated cells (Figure 1). In the case of Toll 
signaling, the NF-κB homologs Dorsal and Dif are activated. 
The imd pathway activates the NF-κB homolog relish. 
Induction of imd signaling also leads to the activation of 
JNK signaling through the kinase dTAK1. This ultimately 
leads to the activation of the two transcription factors, jun-
related antigen (Jra) and AP-1. Immune induction in the ﬂ  y 
is most commonly characterized by the massive induction of 
antimicrobial gene transcription, although many other genes 
are affected both positively and negatively during an immune 
response. When ﬂ  ies are challenged with a nonpathogenic 
elicitor (a molecule or microbe that activates immune 
signaling but doesn’t cause disease), this transcriptional 
response starts, peaks, and then resolves. Focus on this 
pattern recognition–driven immune response has led to a 
cell-autonomous view of ﬂ  y immunity in which microbial 
elicitors induce a cell to respond in the absence of other 
signals.
Two important questions remained unanswered by this 
early work: “How and (perhaps more importantly) why does 
the immune system turn off this activated response?” A simple 
answer to “how?” might be that the immune response turns 
off when the elicitors are cleared. However, work in the 
last 3 years suggests that the story is more complicated and 
that several layers of negative regulation actively turn down 
immune signaling. The answer to “why?” appears to be that 
the immune response causes pathology when it is hyper-
activated.
Negative Regulation of Fly Immunity Can Occur 
through the Clearance of Elicitors
At a very basic level, one might view the clearance of microbes 
as a negative regulator of the immune response—if the 
microbes are gone, there will be no more inducers and the 
immune response is no longer activated. Physical clearance 
of microbes occurs rapidly in ﬂ  ies through the action of 
phagocytic cells called hemocytes. This story is complicated 
because, after phagocytosis (the ingestion of particulates), 
hemocytes release unknown signals that activate a systemic 
immune response [4]. Phagocytes thus remove one signal 
and, at the same time, produce secondary activating signals. 
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Clearance of subcellular microbial elicitors follows a similar 
pattern. The bacterial cell wall component peptidoglycan is 
the chief bacterial elicitor known to activate Toll and imd 
signaling; amidases that degrade peptidoglycan likely help 
clear this material from the circulation. Mutant ﬂ  ies lacking 
these enzymes induce more AMP transcription [5,6]; again, 
this story is complicated because enzymes that degrade 
peptidoglycan also release soluble potent immune elicitors 
from insoluble peptidoglycan and may be required for some 
immune responses, like phagocytosis [7].
Negative Regulation of Fly Immunity Can Occur within 
and between Cells
Besides this clearing activity, both cell-autonomous and 
cell–non-autonomous timing mechanisms exist to turn down 
immune responses. Toll signaling can be repressed by a 
Toll-regulated secreted inhibitor. Toll activation results in 
the transcription of wntD, a member of the wnt family of 
signaling ligands [8,9], forming a simple negative regulatory 
circuit whose timing depends on the kinetics of signaling 
through both the Toll and wntD pathways. The ligand wntD 
signals through an unknown pathway to block nuclear 
translocation of the transcription factor Dorsal; as a result, 
wntD mutants produce higher levels of some antimicrobial 
peptides. These mutants have a counterintuitive immune 
phenotype; they are more sensitive to infections by 
the pathogenic bacterium Listeria monocytogenes. This is 
surprising because an increased immune response might be 
expected to lead to increased survival during an infection. 
In most cases, we don’t understand why ﬂ  ies die when they 
are infected. It is possible that the increased production 
of AMPs uses energy that might otherwise be important 
for survival or that the immune response itself could be 
pathogenic.
The imd pathway is also controlled by a simple negative-
feedback loop. Activation of the imd pathway induces 
transcription of the conserved gene defense repressor 1 (dnr1) 
[10]. Dnr1 is a negative regulator of the caspase Dredd, a 
component of the imd signaling pathway. Presumably, as 
Dnr1 concentrations rise, the imd pathway is shut down.
Activation of the imd pathway leads to signaling through 
both the imd and JNK signaling pathways, and both pathways 
negatively regulate each other. Imd regulates JNK signaling 
by inducing genes downstream of relish that cause the 
degradation of the kinase dTAK1 [11]. Activation of the JNK 
pathway leads to down-regulation of relish activity, which is 
mediated by a protein complex including the JNK target AP-
1 as well as histone deacetylase [12]. The ﬁ  nal result is that 
both JNK and imd signaling ﬂ  ux should be reduced by these 
cell-autonomous negative regulatory circuits.
doi:10.1371/journal.pbio.0050247.g001
Figure 1. Intracellular and Extracellular Negative Regulatory Circuits
Immune activation by peptidoglycan stimulates the Toll and imd signaling pathways, inducing the translocation of the transcription factors Dorsal, 
Dif, and Relish into the nucleus (left panel). This activates an immediate transcriptional response to infection. This response can be attenuated by 
cell-autonomous intracellular signals (right panel) or cell–non-autonomous extracellular signals (bottom panel). All negative regulatory circuits are 
highlighted in red. Note that the Toll and imd pathways are shown in a simpliﬁ  ed form and not all of the components are listed.PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 1849 September 2007  |  Volume 5  |  Issue 9  |  e247
This inhibition of imd signaling through the JNK pathway 
suggests that there might be communication between cells 
leading to immune inhibition. The JNK pathway can be 
activated by Eiger, the sole tumor necrosis factor (TNF) 
homolog in the ﬂ  y [13–15]. In vertebrates, many TNFs are 
soluble, secreted factors that are important regulators of 
immunity. Eiger itself is a secreted immune-induced molecule 
[16,17]. One can easily imagine a circuit in which eiger 
released by one cell limits the induction of imd signaling 
in another. An Eiger-immune phenotype suggests that this 
occurs: eiger mutants produce more imd regulated AMPs 
than do wild-type ﬂ  ies, as would be expected if a negative 
regulator were removed [18].
New research by Kim and colleagues published in this issue 
of PLoS Biology [19] builds on their past work showing that 
JNK signaling inhibits the imd pathway. The authors suggest 
that another extracellular signaling pathway, the JAK/STAT 
pathway, also inhibits imd signaling. Using cultured cells, they 
showed that the transcription factors Jra and Stat93E, which 
act downstream of the JAK/STAT and JNK pathways, can 
bump Relish off a promoter, thereby terminating AMP gene 
transcription and repressing the output of the imd pathway. This 
effect depends on the concentration of transcription factors, 
which increases in the nucleus during immune activation. Both 
Jra and Stat93E are regulated by signaling pathways that are 
induced by extracellular signals. The authors demonstrated 
that STAT activation required the presence of the gene domeless, 
which expresses the receptor in the ﬂ  y JAK/STAT pathway. The 
requirement for JAK/STAT signaling in addition to Stat93E 
concentration suggests that this negative regulatory switch is 
sensitive to extracellular signals. The Domeless-JAK/STAT 
signaling pathway is the ﬂ  y homolog of vertebrate cytokine 
signaling pathways, which are involved in both the positive and 
negative regulation of human immune responses [20].
By moving from a mechanistic description of this signaling 
circuit in cultured cells to a phenotypic description in whole 
ﬂ  ies, the authors demonstrated that reduced Jra or Stat93E 
levels resulted in increased AMP production in whole ﬂ  ies 
during an immune response. As was seen in wntD mutant 
ﬂ  ies, these mutants transcribed more AMP transcripts but 
were more sensitive to infections; thus there are now several 
examples demonstrating that appropriate down-regulation 
of the immune response is important for the survival of ﬂ  ies 
during an infection.
We can now start to put this information together and 
imagine the progress of an infection in the ﬂ  y. Cells at the 
initial site of infection likely respond by producing AMPs, 
nitric oxide, releasing bacterial elicitors of innate immunity, 
and synthesizing other signaling molecules. Multiple factors 
(the amount of microbial material, how it spreads, and 
the pathology it produces) will produce both positive and 
negative immune regulators that will color the systemic 
response of the rest of the ﬂ  y. Thus a ﬂ  y does not receive a 
single signal (“fungus here!”) nor does it robotically respond 
(“turn on AMP expression”); rather, a mixture of signals, in 
combination, allow more nuanced alarms (“fungus present, 
but we’ve got this under control, don’t waste energy ﬁ  ghting 
that infection” or “put everything we’ve got into defense now 
or we are going to die!”) permits more complex, spatially, and 
temporally regulated responses.  
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